SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Canaan Inc. (CAN) (CIK 0001780652) (CAN) — Nov 15, 2019

Canaan Inc. (CAN) (CIK 0001780652)
Date: Nov. 15, 2019 · CIK: 0001780652 · Accession: 0000000000-19-015547

AI Filing Summary & Sentiment

File numbers found in text: 333-234356

Date
November 15, 2019
Author
Not clearly detected
Form
UPLOAD
Company
Canaan Inc. (CAN) (CIK 0001780652)

Letter

November 15, 2019 Nangeng Zhang Chairman and Chief Executive Officer Canaan Inc. 30/F, Dicara Silver Tower 29 Jiefang East Road Jianggan District, Hangzhou 310016 People's Republic of China Re:Canaan Inc. Amendment No. 2 to Registration Statement on Form F-1 Filed November 13, 2019 File No. 333-234356 Dear Mr. Zhang: We have reviewed your registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Amendment No. 2 to Registration Statement on Form F-1 filed November 13, 2019 ADS holders may not be entitled to a jury trial . . ., , page 49 1.Your response to prior comment 2 and current disclosure indicate that claims arising before the withdrawal of the shares underlying the ADSs will continue to be subject to the jury trial waiver provision. Please revise to clarify the basis of that belief. For example, clarify what you consider to be "pre-dispute." If there is material uncertainty regarding the enforceability of this position, please also revise to address this uncertainty. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of

FirstName LastNameNangeng Zhang Comapany NameCanaan Inc. November 15, 2019 Page 2 FirstName LastName Nangeng Zhang Canaan Inc. November 15, 2019 Page 2 action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. You may contact Kristin Lochhead at (202) 551-3664 or Brian Cascio, Accounting Branch Chief, at (202) 551-3676 if you have questions regarding comments on the financial statements and related matters. Please contact Geoff Kruczek at (202) 551-3641 or Jay Ingram, Legal Branch Chief, at (202) 551-3397 with any other questions. Sincerely, Division of Corporation Finance Office of Manufacturing cc: Chris K.H. Lin, Esquire

Show Raw Text
November 15, 2019
Nangeng Zhang
Chairman and Chief Executive Officer
Canaan Inc.
30/F, Dicara Silver Tower
29 Jiefang East Road
Jianggan District, Hangzhou 310016
People's Republic of China
Re:Canaan Inc.
Amendment No. 2 to Registration Statement on Form F-1
Filed November 13, 2019
File No. 333-234356
Dear Mr. Zhang:
            We have reviewed your registration statement and have the following comments.  In
some of our comments, we may ask you to provide us with information so we may better
understand your disclosure.
            Please respond to this letter by amending your registration statement and providing the
requested information.  If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments.
Amendment No. 2 to Registration Statement on Form F-1 filed November 13, 2019
ADS holders may not be entitled to a jury trial . . ., , page 49
1.Your response to prior comment 2 and current disclosure indicate that claims
arising before the withdrawal of the shares underlying the ADSs will continue to be
subject to the jury trial waiver provision.  Please revise to clarify the basis of that belief.
For example, clarify what you consider to be "pre-dispute."  If there is material
uncertainty regarding the enforceability of this position, please also revise to address this
uncertainty.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of

 FirstName LastNameNangeng Zhang
 Comapany NameCanaan Inc.
 November 15, 2019 Page 2
 FirstName LastName
Nangeng Zhang
Canaan Inc.
November 15, 2019
Page 2
action by the staff.
            Refer to Rules 460 and 461 regarding requests for acceleration.  Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
            You may contact Kristin Lochhead at (202) 551-3664 or Brian Cascio, Accounting
Branch Chief, at (202) 551-3676 if you have questions regarding comments on the financial
statements and related matters.  Please contact Geoff Kruczek at (202) 551-3641 or Jay Ingram,
Legal Branch Chief, at (202) 551-3397 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc:       Chris K.H. Lin, Esquire